Status:
COMPLETED
Intraocular Pressure Immediately Following Intravitreous Injection of Ranibizumab
Lead Sponsor:
Oklahoma State University Center for Health Sciences
Conditions:
Choroidal Neovascularization
Eligibility:
All Genders
18+ years
Brief Summary
This study will quantify the intraocular pressure elevation in the immediate time period following intravitreous injection. With more widespread use of intravitreous injections in patients that may re...
Detailed Description
We will assess the trend of intraocular pressure immediately following intravitreal injection of ranibizumab 0.5 mg (0.05 mL) by taking serial intraocular pressure readings every five minutes for thir...
Eligibility Criteria
Inclusion
- Male or Female Patients \>18 years of age
- Patients will have documented choroidal neovascular membranes on fluorescein angiogram and/or optical coherence tomography
- Requiring treatment or maintenance therapy for choroidal neovascular membrane
- Able and willing to provide written informed consent
Exclusion
- History of arterial occlusive disease of the eye.
- History of advanced glaucoma.
Key Trial Info
Start Date :
January 1 2007
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
January 1 2008
Estimated Enrollment :
75 Patients enrolled
Trial Details
Trial ID
NCT00417703
Start Date
January 1 2007
End Date
January 1 2008
Last Update
January 24 2008
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Retina Support Services, Inc
Tulsa, Oklahoma, United States, 74127